MEDIPOST announced on February 4 that the company website (en.medi-post.co.kr) was reorganized overall.
MEDIPOST arranged stem cell drug information highly interested by the homepage visitors on the initial screen page and reinforced introduction of GMP production facility and R&D area.
Especially, active communication space was expanded by opening online inquiry corner about ‘CARTISTEM®’, a knee cartilage regeneration drug which more patients are injected with increasingly.
In addition, it was made to optimize size and composition of the screen according to users’ devices such as PC, smart phone, and tablet PC by applying reactive web technology.
Besides, MEDIPOST enabled application of the company tour program to visit its stem cell exhibition center, cord blood experience center, and research facility in this newly reorganized website.
Additionally, MEDIPOST is going to begin online promotion actively targeting foreign users by reorganizing English websites as well as Korean.